Improvement of Diabetic Macular Oedema with Intravitreal Dobesilate: A Case Report
Journal: Austin Journal of Clinical Case Reports (Vol.1, No. 10)Publication Date: 2014-09-11
Authors : Cuevas P; Outeiriño LA; Azanza C; Angulo J; Giménez-Gallego G;
Page : 1-2
Keywords : Diabetic retinopathy; Fibroblast growth factor; Dobesilate;
Abstract
A single Intravitreal injection of Dobesilate seems to provide improvement in visual acuity and macular anatomy in a patient with diabetic macular oedema. To our knowledge, this is the first clinical case report using Intravitreal Dobesilate for diabetic macular oedema treatment. The therapeutic effect of Dobesilate may be due to the local inhibition of fibroblast growth factor.
Other Latest Articles
Last modified: 2016-07-27 17:36:38